Comments requested on documents for the use of ISBT 128 for coding and labeling of cellular therapy products
Pat Distler, Technical Director of ICCBBA (attribution used with permission) reports that representatives from AABB, ASBMT, ASFA, EBMT, FACT, ICCBBA, ISBT, ISCT, ISCT Europe, JACIE, NMDP and WMDA have written documents for the use of ISBT 128 for cellular therapy products. These documents are available for public comment at: http://www.iccbba.org/ctcomments.html (link no longer available)
Editors' note: Comments shared with the e-Network Forum are also welcome.
Submit comments to the e-Network Forum at enetworkforum@cbbsweb.org
Ira A. Shulman, MD
CBBS e-Network Forum Senior Editor & Moderator
W. Tait Stevens, MD
CBBS e-Network Forum Editor & Moderator
Elizabeth M. St. Lezin, MD
CBBS e-Network Forum Associate Editor & Moderator
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
